Subacute sclerosing panencephalitis manifesting as viral retinitis: Clinical and histopathologic findings

American Journal of Ophthalmology

Volumn 123, Issue 4, 1997, Pages 533-542

  Park, D W ^a   Boldt, H C ^a   Massicotte, S J ^a   Akang, E E U ^a   Roos, K L ^a   Bodnar, A ^a   Pless, J ^a   Ghetti, B ^a   Pascuzzi, R M ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELL ULTRASTRUCTURE; DIFFERENTIAL DIAGNOSIS; DRUG ABUSE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INFECTION RISK; MALE; PREVALENCE; PRIORITY JOURNAL; RETINITIS; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0030893393     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)70179-5     Document Type: Article

References (47)

1. Selik RM Chu SY Buehler JW HIV infection as leading cause of death among young adults in US cities and states JAMA 269 1993 2991 2994
2. Chaisson RE Kerule JC Moore RD Race, sex, drug use, and progression of human immunodeficiency virus disease N Engl J Med 333 1995 751 756
3. Dawson JR Jr Cellular inclusions in cerebral lesions of lethargic encephalitis Am J Pathol 9 1933 7 16
4. Modlin JF Halsey NA Eddins DL Epidemiology of subacute sclerosing panencephalitis J Pediatr 94 1979 231 236
5. Hall WW Lamb RA Choppin PW Measles and SSPE virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis Proc Natl Acad Sci U S A 76 1979 2047 2051
6. Johnson KP Norrby E Swoveland P Carrigan DR Experimental subacute sclerosing panencephalitis: selective disappearance of measles virus matrix protein from the central nervous system J Infect Dis 144 1981 161 191
7. Taylor WJ DuRant RH Dyken PR Treatment of subacute sclerosing panencephalitis: an overview Drug Intell Clin Pharm 18 1984 375 381
8. Hiatt RL Gizzard HT McNeer P Jabbour JT Ophthalmologic manifestations of subacute sclerosing panencephalitis (Dawsons encephalitis) Trans Am Acad Ophthalmol Otolaryngol 75 1971 344 350
9. Green SH Wirtschafter JD Ophthalmoscopic findings in subacute sclerosing panencephalitis Br J Ophthalmol 57 1973 780 787
10. Morgan B Cohen DN Rothner AD Williamson R Ocular manifestations of subacute sclerosing panencephalitis Am J Dis Child 130 1976 1019 1021
11. Robb RM Watters GV Ophthalmic manifestation of subacute sclerosing panencephalitis Arch Ophthalmol 83 1970 426 435
12. Salmon JF Pan EL Murray ADN Visual loss with dancing extremities and mental disturbances Surv Ophthalmol 35 1991 299 306
13. Otradovec J Chorioretinitis centralis bei leucoencephalitis subacuta sclerotisans Van Bogaert Ophthalmologica 146 1963 65 73
14. Nelson DA Weiner A Yanoff M de Pesalta J Retinal lesions in subacute sclerosing panencephalitis Arch Ophthalmol 84 1970 613 621
15. DeLaey JJ Hanssens M Colette P Geerts L Priem H Subacute sclerosing panencephalitis: fundus changes and histopathologic correlations Doc Ophthalmol 56 1983 11 21
16. Landers MB Klintworth GK Subacute sclerosing panencephalitis (SSPE) Arch Ophthalmol 86 1971 156 163
17. Meyers E Mailin M Zonis S Subacute sclerosing panencephalitis: clinicopathological study of the eyes J Pediatr Ophthalmol Strabismus 15 1978 19 23
18. Kovacs B Vastag O Fluoroangiographic picture of the acute stage of the retinal lesion in subacute sclerosing panencephalitis Ophthalmologica 177 1978 264 269
19. Zagami AS Lethlean AK Chorioretinitis as a possible very early manifestation of subacute sclerosing panencephalitis Aust N Z J Med 21 1991 350 352
20. Font RL Jenis EH Tuck KD Measles maculopathy associated with subacute sclerosing panencephalitis Arch Pathol 96 1973 168 174
21. Grayina RF Nakarishi AS Faden A Subacute sclerosing panencephalitis Am J Ophthalmol 86 1978 106 109
22. Brudet-Wickel CLM Hogweg M DeWolff-Rouendaal D Subacute sclerosing panencephalitis (SSPE) Doc Ophthalmol 52 1982 241 249
23. LaPiana FG Tso MOM Jenis EH The retinal lesions of subacute sclerosing panencephalitis Ann Ophthalmol 6 1974 603 610
24. Raymond LA Kerstine RS Shelburne SA Preretinal vitreous membrane in subacute sclerosing panencephalitis Arch Ophthalmol 94 1976 1412 1413
25. Andrida M Karlsberg RO Maculopathy in subacute sclerosing panencephalitis Am J Dis Child 124 1972 187 189
26. Swoveland PT Molecular events in measles virus infection of the central nervous system Int Rev Exp Pathol 32 1991 255 275
27. Sever JL Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis Rev Infect Dis 5 1983 467 473
28. Aaby P Bukh J Lisse IM Smits AJ Risk factors in subacute sclerosing panencephalitis: age- and sex-dependent host reactions or intensive exposure Rev Infect Dis 6 1984 239 250
29. Jabbour JT Garcia JH Lemmi H Ragland J Duenas DA Sever JL Subacute sclerosing panencephalitis: a multidisciplinary study of eight cases JAMA 207 1969 2248 2254
30. Markand ON Panszi JG The electroencephalogram in subacute sclerosing panencephalitis Arch Neurol 32 1975 719 726
31. Hall WW Choppin PW Measles virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis: absence of M protein N Engl J Med 304 1981 1152 1155
32. Norrby E Kristensson K Brzosko WJ Kapsenberg JG Measles virus matrix protein detected by immune fluorescence with monoclonal antibodies in the brain of patients with subacute sclerosing panencephalitis J Virol 56 1985 337 340
33. Cattaneo R Rebmann G Baczko K Meulen V Billeter MA Altered ratios of measles virus transcripts in diseased human brains Virology 160 1987 523 526
34. Fukuyama Y Nihei K Matsumoto S Clinical effects of MND-9 (inosiplex) on subacute sclerosing panencephalitis Brain Dev 9 1987 270 282
35. Anlar B Yalaz K Imir T Turanh G The effect of inosiplex in subacute sclerosing panencephalits: a clinical and laboratory study Eur Neurol 34 1994 44 47
36. Sone S Maeda K Haginoya K A clinical trial of interferon therapy in a case of rapidly progressive SSPE Brain Dev 8 1986 636 640
37. Yoshioka H Nishimura O Nakagawa M Administrations of human leukocyte interferon to patients with subacute sclerosing panencephalitis Brain Dev 11 1989 302 307
38. Miyazaki M Hashimoto T Fujino K Goda T Tayama M Kuroda Y Apparent response of subacute sclerosing panencephalitis to intrathecal interferon alpha Ann Neurol 29 1991 97 99
39. Huttenlocher PR Picchietti DL Roos RP Cashman NR Horowitz B Horowitz MS Intrathecal interferon in subacute sclerosing panencephalitis Ann Neurol 19 1986 303 305
40. Jones CE Dyken PR Huttenlocher PR Jabbour JT Maxwell KW Inosiplex therapy in subacute sclerosing panencephalitis: a multicentre, nonrandomized study in 98 patients Lancet 1 1982 1034 1037
41. Philippart M SSPE and interferon. Letter to the Editor Brain Dev 16 1994 18
42. Panitch HS Goez-Plascencia J Norris FH Cantell K Smith RA Subacute sclerosing panencephalitis: remission after treatment with intraventricular interferon Neurology 36 1986 562 566
43. Kuroki S Tsutsui T Yoshioka M Mizue H Kita M Kishida T The effect of intraventricular interferon on subacute sclerosing panencephalitis Brain Dev 11 1989 65 69
44. Steiner I Wirguin I Morag A Abramsky O Intraventricular interferon treatment for subacute sclerosing panencephalitis J Child Neurol 4 1989 20 23
45. Yalaz K Anlar B Oktem F Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis Neurology 42 1992 488 491
46. Gascon G Yamani S Crowell J Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis Brain Dev 15 1993 346 355
47. Cremer NE Cossen CK Shell G Diggs J Gallo D Schmidt NJ Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-roster viruses and versus complement fixation for serodiagnosis of infection with those viruses J Clin Microbiol 21 1985 869 874